Zi‐Fan Yu
About
Zi‐Fan Yu is a scholar working on Molecular Biology, Ophthalmology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Zi‐Fan Yu has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Ophthalmology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zi‐Fan Yu's work include Retinal Diseases and Treatments (10 papers), Retinal Development and Disorders (10 papers) and Lysosomal Storage Disorders Research (3 papers). Zi‐Fan Yu is often cited by papers focused on Retinal Diseases and Treatments (10 papers), Retinal Development and Disorders (10 papers) and Lysosomal Storage Disorders Research (3 papers). Zi‐Fan Yu collaborates with scholars based in United States, France and United Kingdom. Zi‐Fan Yu's co-authors include R. Scott Mitchell, Joel Verter, Michel S. Makaroun, Jehangir J. Appoo, Joseph E. Bavaria, Jean Bennett, Katherine A. High, Daniel C. Chung, Paul Harmatz and Elisa Leão Teles and has published in prestigious journals such as PEDIATRICS, Biometrics and Ophthalmology.
In The Last Decade
Zi‐Fan Yu
19 papers receiving 1.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Zi‐Fan Yu United States | 11 | 546 | 476 | 412 | 329 | 286 | 19 | 1.5k | ||
| Maria Gisele Matheus United States | 11 | 147 0.3× | 259 0.5× | 208 0.5× | 145 0.4× | 40 0.1× | 16 | 661 | ||
| Julie E. Hammack United States | 20 | 226 0.4× | 113 0.2× | 447 1.1× | 290 0.9× | 48 0.2× | 35 | 1.8k | ||
| Fady Joseph United Kingdom | 14 | 162 0.3× | 226 0.5× | 183 0.4× | 68 0.2× | 84 0.3× | 23 | 1.0k | ||
| Lei Cui China | 22 | 333 0.6× | 145 0.3× | 93 0.2× | 57 0.2× | 60 0.2× | 108 | 1.3k | ||
| Catherine Vignal France | 20 | 632 1.2× | 72 0.2× | 98 0.2× | 141 0.4× | 563 2.0× | 126 | 1.5k | ||
| Xiaoyan Li China | 15 | 339 0.6× | 109 0.2× | 139 0.3× | 67 0.2× | 98 0.3× | 68 | 1.0k | ||
| G A Lammie United Kingdom | 16 | 205 0.4× | 139 0.3× | 325 0.8× | 279 0.8× | 10 0.0× | 23 | 1.2k | ||
| Jean‐Claude Décarie Canada | 21 | 402 0.7× | 55 0.1× | 136 0.3× | 105 0.3× | 36 0.1× | 43 | 1.1k | ||
| Sung Yoon Cho South Korea | 19 | 260 0.5× | 287 0.6× | 45 0.1× | 178 0.5× | 27 0.1× | 105 | 939 | ||
| Tommaso Susini Italy | 23 | 205 0.4× | 82 0.2× | 182 0.4× | 81 0.2× | 22 0.1× | 79 | 1.4k |
Countries citing papers authored by Zi‐Fan Yu
Since
Specialization
Citations
This map shows the geographic impact of Zi‐Fan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi‐Fan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi‐Fan Yu more than expected).
Fields of papers citing papers by Zi‐Fan Yu
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Zi‐Fan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi‐Fan Yu. The network helps show where Zi‐Fan Yu may publish in the future.
Co-authorship network of co-authors of Zi‐Fan Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Zi‐Fan Yu. A scholar is included among the top collaborators of Zi‐Fan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zi‐Fan Yu. Zi‐Fan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bennett, Jean, Stephen R. Russell, Katherine A. High, et al.. (2021). Five-Year Post-Injection Results of the Phase 3 Trial of Voretigene Neparvovec-rzyl in Biallelic RPE65 Mutation-Associated Inherited Retinal Disease. Investigative Ophthalmology & Visual Science. 62(8). 3540–3540.
2.
Maguire, Albert M., Stephen R. Russell, Daniel C. Chung, et al.. (2021). Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease. Ophthalmology. 128(10). 1460–1468.
3.
Leroy, Bart P., Stephen R. Russell, Jean Bennett, et al.. (2021). 89 Five-year update for the Phase III voretigene neparvovec study in biallelic RPE65 mutation–associated inherited retinal disease. Abstracts. A37.3–A38.
4.
Maguire, Albert M., Stephen R. Russell, Jennifer Wellman, et al.. (2019). Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy. Ophthalmology. 126(9). 1273–1285.
5.
Drack, Arlene V., Jean Bennett, Stephen R. Russell, et al.. (2019). How long does gene therapy last? 4-year follow-up of phase 3 voretigene neparvovec trial in RPE65-associated LCA/inherited retinal disease. Journal of American Association for Pediatric Ophthalmology and Strabismus. 23(4). e7–e7.
6.
Russell, Stephen R., Jean Bennett, Jennifer Wellman, et al.. (2018). Three-year update for the phase 3 voretigene neparvovec study in biallelic RPE65 mutation–associated inherited retinal disease. Investigative Ophthalmology & Visual Science. 59(9). 3900–3900.
7.
Schreiber, George B., et al.. (2018). Frequent source plasma donors are not at risk of iron depletion: the Ferritin Levels in Plasma Donor (FLIPD) study. Transfusion. 58(4). 951–959.
8.
Drack, Arlene V., Jean Bennett, Stephen R. Russell, et al.. (2018). Year 3 results and age-stratified analyses for a phase 3 trial of voretigene neparvovec in RPE65 mutation-associated inherited retinal disease. Journal of American Association for Pediatric Ophthalmology and Strabismus. 22(4). e13–e13.
9.
Chung, Daniel C., Stephen R. Russell, Jean Bennett, et al.. (2017). Correlation of multi-luminance mobility testing with visual function tests in a phase 3 trial of voretigene neparvovec for biallelic RPE65-mediated inherited retinal disease. Investigative Ophthalmology & Visual Science. 58(8). 3292–3292.
10.
Russell, Stephen R., Jean Bennett, Jennifer Wellman, et al.. (2017). Year 2 results for a phase 3 trial of voretigene neparvovec in biallelic RPE65-mediated inherited retinal disease. Investigative Ophthalmology & Visual Science. 58(8). 4122–4122.
11.
Chung, Daniel C., Sarah McCague, Zi‐Fan Yu, et al.. (2017). Novel mobility test to assess functional vision in patients with inherited retinal dystrophies. Clinical and Experimental Ophthalmology. 46(3). 247–259.
12.
Beggs, Alan H., Barry J. Byrne, Tmirah Haselkorn, et al.. (2017). A multicenter, retrospective medical record review of X‐linked myotubular myopathy: The recensus study. Muscle & Nerve. 57(4). 550–560.
13.
Moukarbel, George V., Zi‐Fan Yu, Kenneth Dickstein, et al.. (2013). The Impact of Kidney Function on Outcomes Following High Risk Myocardial Infarction: Findings from 27 610 Patients. European Journal of Heart Failure. 16(3). 289–299.
14.
Decker, Celeste, Zi‐Fan Yu, Roberto Giugliani, et al.. (2010). Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. Journal of Pediatric Rehabilitation Medicine. 3(2). 89–100.
15.
Bavaria, Joseph E., Jehangir J. Appoo, Michel S. Makaroun, et al.. (2007). Endovascular stent grafting versus open surgical repair of descending thoracic aortic aneurysms in low-risk patients: A multicenter comparative trial. Journal of Thoracic and Cardiovascular Surgery. 133(2). 369–377.e4.
16.
Harmatz, Paul, Roberto Giugliani, Ida Vanessa Döederlein Schwartz, et al.. (2006). Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. The Journal of Pediatrics. 148(4). 533–539.e6.
17.
Yu, Zi‐Fan & Paul J. Catalano. (2005). Quantitative Risk Assessment for Multivariate Continuous Outcomes with Application to Neurotoxicology: The Bivariate Case. Biometrics. 61(3). 757–766.
18.
Harmatz, Paul, David Ketteridge, Roberto Giugliani, et al.. (2005). Direct Comparison of Measures of Endurance, Mobility, and Joint Function During Enzyme-Replacement Therapy of Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome): Results After 48 Weeks in a Phase 2 Open-Label Clinical Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase. PEDIATRICS. 115(6). e681–e689.
19.
Rajdev, Lakshmi, Zi‐Fan Yu, Scott Wadler, et al.. (2001). N-Methylformamide in Advanced Squamous Cancer of the Uterine Cervix: An Eastern Cooperative Oncology Group Phase II Trial. Investigational New Drugs. 19(3). 233–237.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Maria Gisele Matheus Breakdown of academic impact, for papers by Julie E. Hammack Breakdown of academic impact, for papers by Fady Joseph Breakdown of academic impact, for papers by Lei Cui Breakdown of academic impact, for papers by Catherine Vignal Breakdown of academic impact, for papers by Xiaoyan Li Breakdown of academic impact, for papers by G A Lammie Breakdown of academic impact, for papers by Jean‐Claude Décarie Breakdown of academic impact, for papers by Sung Yoon Cho Breakdown of academic impact, for papers by Tommaso Susini